Edition:
United Kingdom

Hologic Inc (HOLX.OQ)

HOLX.OQ on NASDAQ Stock Exchange Global Select Market

42.38USD
10 Dec 2018
Change (% chg)

$0.40 (+0.95%)
Prev Close
$41.98
Open
$41.98
Day's High
$42.59
Day's Low
$41.44
Volume
620,390
Avg. Vol
722,747
52-wk High
$45.12
52-wk Low
$35.10

Latest Key Developments (Source: Significant Developments)

Hologic - Cynosure Elected To Suspend Marketing & Distribution Of Vitalia Handpieces & Single-Use Probes
Monday, 13 Aug 2018 

Aug 13 (Reuters) - Hologic Inc ::HOLOGIC INC - CYNOSURE ELECTED TO SUSPEND MARKETING & DISTRIBUTION OF VITALIA HANDPIECES & SINGLE-USE PROBES.HOLOGIC INC - CYNOSURE ASKING CUSTOMERS TO RETURN ANY VITALIA HANDPIECES, UNUSED PROBES PURCHASED.HOLOGIC INC - CYNOSURE'S SUSPENSION UNTIL IT CONFIRMS ALL REGULATORY REQUIREMENTS MET FOR DEVICES IN CATEGORY.HOLOGIC SAYS TEMPSURE SYSTEM REMAINS FDA-CLEARED AND MAY CONTINUE TO BE USED WITH VARIOUS OTHER HANDPIECES, INCLUDING TEMPSURE ENVI.HOLOGIC SAYS ACTION LIMITED TO VITALIA PROBE & HANDPIECE; DOES NOT AFFECT OTHER HOLOGIC GYNECOLOGY PRODUCTS - SEC FILING.HOLOGIC INC - CYNOSURE HAD NO REPORTS OF ADVERSE EFFECTS FROM USE OF VITALIA HANDPIECE, PROBE; NOT BEEN MADE AWARE OF PATIENT HARM ASSOCIATED WITH USE.HOLOGIC INC - TEMPSURE SYSTEM REMAINS FDA-CLEARED AND MAY CONTINUE TO BE USED WITH ITS VARIOUS OTHER HANDPIECES, INCLUDING TEMPSURE ENVI.HOLOGIC - ANY RETURNS OF VITALIA HANDPIECES, UNUSED PROBES AND TEMPSURE SYSTEMS EXPECTED TO BE RECORDED AS REDUCTION TO REVENUE, PRIMARILY IN Q4.HOLOGIC - BECAUSE NUMBER OF RETURNS UNCERTAIN, CO UNABLE TO ACCURATELY FORECAST FINANCIAL EFFECT.  Full Article

Hologic To Acquire Faxitron Bioptics For About $85 Million
Tuesday, 31 Jul 2018 

July 31 (Reuters) - Hologic Inc ::HOLOGIC TO ACQUIRE FAXITRON BIOPTICS, LEADER IN DIGITAL SPECIMEN RADIOGRAPHY, FOR APPROXIMATELY $85 MILLION.HOLOGIC INC - DEAL FOR APPROXIMATELY $85 MILLION.HOLOGIC - DEAL IS EXPECTED TO BE ROUGHLY NEUTRAL TO HOLOGIC'S NON-GAAP EARNINGS PER SHARE FOR REMAINDER OF FISCAL 2018 AND FISCAL 2019.HOLOGIC - ACQUISITION IS EXPECTED TO BE ACCRETIVE AFTER FISCAL 2019.  Full Article

Hologic - U.S. International Trade Commission Judge Issued Favorable Initial Ruling In Patent Infringement Complaint
Monday, 30 Jul 2018 

July 30 (Reuters) - Fujifilm Holdings Corp <4901.T>::HOLOGIC - U.S. INTERNATIONAL TRADE COMMISSION JUDGE ISSUED FAVORABLE INITIAL RULING IN PATENT INFRINGEMENT COMPLAINT INVESTIGATION FILED AGAINST FUJIFILM.HOLOGIC - FINAL RULING BY ITC ON INVESTIGATION OF PATENT INFRINGEMENT COMPLAINT FILED BY CO AGAINST FUJIFILM SCHEDULED TO ISSUE BY NOV 26, 2018.HOLOGIC - AS A RESULT OF THE ITC RULING, JUDGE RECOMMENDED AN EXCLUSION ORDER THAT PREVENTS THE IMPORTATION OF INFRINGING FUJIFILM PRODUCTS INTO U.S..HOLOGIC-AS A RESULT OF ITC RULING, JUDGE RECOMMENDED CEASE-AND-DESIST ORDER PREVENTING FURTHER SALE, MARKETING OF INFRINGING FUJIFILM PRODUCTS IN U.S..  Full Article

Hologic Announces Pricing Of Offering Of $1 Bln Of Senior Notes
Wednesday, 17 Jan 2018 

Jan 16 (Reuters) - Hologic Inc ::HOLOGIC ANNOUNCES PRICING OF OFFERING OF $1 BILLION OF SENIOR NOTES.PRICED ‍$600 MILLION AGGREGATE PRINCIPAL AMOUNT OF ADDITIONAL 4.375% SENIOR NOTES DUE 2025 AT AN ISSUE PRICE OF $1,000 PER $1,000​.‍ PRICED $400 MILLION AGGREGATE PRINCIPAL AMOUNT OF 4.625% SENIOR NOTES DUE 2028 AT AN ISSUE PRICE OF $1,000 PER $1,000​.  Full Article

Hologic Announces Offering Of $1 Billion Of Senior Notes
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - Hologic Inc ::HOLOGIC ANNOUNCES OFFERING OF $1 BILLION OF SENIOR NOTES.HOLOGIC - LAUNCHED $1 BILLION OF SENIOR NOTES WHICH IS TO BE ALLOCATED BETWEEN ADDITIONAL 4.375% SENIOR NOTES DUE 2025 AND NEW SENIOR NOTES DUE 2028.HOLOGIC SAYS TO USE PROCEEDS OF OFFERING, AVAILABLE CASH TO REDEEM OUTSTANDING $1.0 BILLION 5.25% SENIOR NOTES DUE 2022.  Full Article

Third Respiratory Assay now FDA cleared on Hologic's new Panther Fusion system
Wednesday, 6 Dec 2017 

Dec 6 (Reuters) - Hologic Inc ::THIRD RESPIRATORY ASSAY NOW FDA CLEARED ON HOLOGIC'S NEW PANTHER FUSION® SYSTEM.HOLOGIC INC - ‍RECEIVED 510(K) CLEARANCE FROM FDA FOR PANTHER FUSION ADV/HMPV/RV ASSAY, A MULTIPLEXED ASSAY THAT RUNS ON NEW PANTHER FUSION SYSTEM​.  Full Article

HOLOGIC RECEIVES FDA 510(K) CLEARANCE OF QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE
Friday, 24 Nov 2017 

Nov 24 (Reuters) - Hologic Inc ::HOLOGIC RECEIVES FDA 510(K) CLEARANCE OF QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE.HOLOGIC INC- ‍HAS RECEIVED 510(K) CLEARANCE FROM U.S. FOOD AND DRUG ADMINISTRATION FOR QUANTRA 2.2 BREAST DENSITY ASSESSMENT SOFTWARE​.  Full Article

Hologic announces Q4 GAAP earnings per share $0.29
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Hologic Inc ::Hologic announces financial results for fourth quarter of fiscal 2017.Q4 non-GAAP earnings per share $0.50.Q4 GAAP earnings per share $0.29.Q4 earnings per share view $0.49 -- Thomson Reuters I/B/E/S.Q4 revenue $802.9 million versus I/B/E/S view $792.5 million.Hologic Inc - ‍expect to post solid, mid-single-digit organic revenue growth in fiscal 2018​.  Full Article

Hologic - ‍received 510(k) clearance from FDA for Panther Fusion Paraflu assay​
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Hologic Inc :Hologic Inc - ‍received 510(k) clearance from FDA for Panther Fusion Paraflu assay​.  Full Article

FDA grants PMA approval for Hologic's Aptima hepatitis C Quant DX Assay
Wednesday, 15 Feb 2017 

Hologic Inc :FDA grants PMA approval for Hologic's Aptima hepatitis C Quant DX Assay.  Full Article